Arvinas Inc header image

Arvinas Inc

ARVN

Equity

ISIN US04335A1051 / Valor 43526042

NASDAQ (2024-11-22)

USD 25.86+2.99%

Arvinas Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Arvinas Inc, founded by Yale professor Craig Crews, focuses on developing PROTAC® protein degraders as potential therapies for patients with cancers and other challenging diseases. The company's proprietary PROTAC® technology utilizes the body's natural protein disposal system to target and eliminate disease-causing proteins, offering a potentially transformative approach to treatment.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

20.8%1Y

-68.6%3Y

-25.4%5Y

Performance

66.3%1Y

66.5%3Y

73.1%5Y

Volatility

1927 M

Market cap (USD)

276,493

Daily traded volume (Shares)

25.37 / 22.635

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Afya Ltd

Afya Ltd Valor: 48661743

Annual Return

-50%0%+50%

Risk level

110

2.95%USD 16.74

Medacta Group Ltd

Medacta Group Ltd Valor: 46852522

Annual Return

-50%0%+50%

Risk level

110

2.21%CHF 110.80

Haemonetics Corp

Haemonetics Corp Valor: 937449

Annual Return

-50%0%+50%

Risk level

110

0.60%USD 85.43

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Valor: 2791431

Annual Return

-50%0%+50%

Risk level

110

-1.10%CHF 7.20

Coloplast A/S

Coloplast A/S Valor: 20259063

Annual Return

-50%0%+50%

Risk level

110

2.11%DKK 891.60

Demant A/S

Demant A/S Valor: 32651962

Annual Return

-50%0%+50%

Risk level

110

3.18%DKK 266.20

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

-1.10%DKK 35.90

Sanofi SA

Sanofi SA Valor: 699381

Annual Return

-50%0%+50%

Risk level

110

0.08%EUR 90.87

Sartorius Stedim Biotech

Sartorius Stedim Biotech Valor: 32518471

Annual Return

-50%0%+50%

Risk level

110

0.33%EUR 168.60

Stride Inc

Stride Inc Valor: 58406765

Annual Return

-50%0%+50%

Risk level

110

0.59%USD 103.41

SIX

FactSet

Clearbit

Logos provided by Clearbit